In the present work, we aimed to evaluate the expression of molecules that participate in VEGF and Ang–Tie pathways in ACT and its potential use for fine-tuning differential diagnosis and/or prediction of ACC prognosis. This evidence concerns the gene TIE1 and adrenal cortex carcinoma.